In addition, MSC treatment with a ×0.2, ×2, or ×20 of the standard dose in MSA animals decreased significantly Annexin V‐positive cells in the frontal cortex compared with MSA animals receiving placebo. Here, ANXA5 is linked to multiple system atrophy.